Form 4: Syros Pharmaceuticals Executive Exercises Stock Options, Sells Shares for Tax Obligations
SEC Form 4 Filing
Gerald E. Quirk, Chief Legal & Compliance Officer of Syros Pharmaceuticals, exercised stock options and sold shares to cover tax obligations on September 30, 2024.
Summary
- On September 30, 2024, Gerald E. Quirk, the Chief Legal & Compliance Officer of Syros Pharmaceuticals, exercised restricted stock units, receiving 10,000 shares of common stock.
- Quirk then sold 3,100 shares at a price of $2.1 per share to cover tax withholding obligations related to the vesting of the restricted stock units.
- Following these transactions, Quirk directly owns 46,657 shares of Syros Pharmaceuticals common stock and 20,000 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine transaction related to executive compensation and tax obligations. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 09/12/2023 | Date of restricted stock unit award grant. |
| 09/30/2024 | Date of transaction: Exercise of restricted stock units and sale of shares. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Keywords
Syros Pharmaceuticals, SYRS, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Gerald E. Quirk, Executive Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.